Fibroblast Growth Factor 23 Predicts Left Ventricular Mass and Induces Cell Adhesion Molecule Formation

Elevated FGF-23 is a predictor of mortality and is associated with LVH in CKD. It may be a biomarker or a direct toxin. We assessed the relationship between FGF-23 and LVH in CKD using CMRI. In vitro we studied the effect of phosphate, FGF-23, and Klotho on E-selectin and VCAM production in HUVECs....

Full description

Saved in:
Bibliographic Details
Main Authors: Kathryn K. Stevens, Emily P. McQuarrie, William Sands, Dianne Z. Hillyard, Rajan K. Patel, Patrick B. Mark, Alan G. Jardine
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.4061/2011/297070
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849684664398118912
author Kathryn K. Stevens
Emily P. McQuarrie
William Sands
Dianne Z. Hillyard
Rajan K. Patel
Patrick B. Mark
Alan G. Jardine
author_facet Kathryn K. Stevens
Emily P. McQuarrie
William Sands
Dianne Z. Hillyard
Rajan K. Patel
Patrick B. Mark
Alan G. Jardine
author_sort Kathryn K. Stevens
collection DOAJ
description Elevated FGF-23 is a predictor of mortality and is associated with LVH in CKD. It may be a biomarker or a direct toxin. We assessed the relationship between FGF-23 and LVH in CKD using CMRI. In vitro we studied the effect of phosphate, FGF-23, and Klotho on E-selectin and VCAM production in HUVECs. FGF-23 concentration correlates negatively with eGFR and positively with LVMI. FGF-23 was an independent predictor of LVH in CKD. E-selectin and VCAM production was elevated in HUVECs cultured in high phosphate with FGF-23 or Klotho. This effect was attenuated in cells exposed to both FGF-23 and Klotho. FGF-23 is an independent predictor of LVH as measured by CMRI. We show preliminary data which supports that FGF-23 is toxic resulting in activation of the vascular endothelium. We do not prove causality with elevated FGF-23 and LVH. Further research should ascertain if lowering levels of FGF-23 translates to improved clinical outcomes.
format Article
id doaj-art-c0ffd1a3298d49cd86603239a957438a
institution DOAJ
issn 2090-214X
2090-2158
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-c0ffd1a3298d49cd86603239a957438a2025-08-20T03:23:24ZengWileyInternational Journal of Nephrology2090-214X2090-21582011-01-01201110.4061/2011/297070297070Fibroblast Growth Factor 23 Predicts Left Ventricular Mass and Induces Cell Adhesion Molecule FormationKathryn K. Stevens0Emily P. McQuarrie1William Sands2Dianne Z. Hillyard3Rajan K. Patel4Patrick B. Mark5Alan G. Jardine6Renal Research Group, ICAMS, University of Glasgow, 126 University Place, Glasgow G12 8TA, UKRenal Research Group, ICAMS, University of Glasgow, 126 University Place, Glasgow G12 8TA, UKRenal Research Group, ICAMS, University of Glasgow, 126 University Place, Glasgow G12 8TA, UKRenal Research Group, ICAMS, University of Glasgow, 126 University Place, Glasgow G12 8TA, UKRenal Research Group, ICAMS, University of Glasgow, 126 University Place, Glasgow G12 8TA, UKRenal Research Group, ICAMS, University of Glasgow, 126 University Place, Glasgow G12 8TA, UKRenal Research Group, ICAMS, University of Glasgow, 126 University Place, Glasgow G12 8TA, UKElevated FGF-23 is a predictor of mortality and is associated with LVH in CKD. It may be a biomarker or a direct toxin. We assessed the relationship between FGF-23 and LVH in CKD using CMRI. In vitro we studied the effect of phosphate, FGF-23, and Klotho on E-selectin and VCAM production in HUVECs. FGF-23 concentration correlates negatively with eGFR and positively with LVMI. FGF-23 was an independent predictor of LVH in CKD. E-selectin and VCAM production was elevated in HUVECs cultured in high phosphate with FGF-23 or Klotho. This effect was attenuated in cells exposed to both FGF-23 and Klotho. FGF-23 is an independent predictor of LVH as measured by CMRI. We show preliminary data which supports that FGF-23 is toxic resulting in activation of the vascular endothelium. We do not prove causality with elevated FGF-23 and LVH. Further research should ascertain if lowering levels of FGF-23 translates to improved clinical outcomes.http://dx.doi.org/10.4061/2011/297070
spellingShingle Kathryn K. Stevens
Emily P. McQuarrie
William Sands
Dianne Z. Hillyard
Rajan K. Patel
Patrick B. Mark
Alan G. Jardine
Fibroblast Growth Factor 23 Predicts Left Ventricular Mass and Induces Cell Adhesion Molecule Formation
International Journal of Nephrology
title Fibroblast Growth Factor 23 Predicts Left Ventricular Mass and Induces Cell Adhesion Molecule Formation
title_full Fibroblast Growth Factor 23 Predicts Left Ventricular Mass and Induces Cell Adhesion Molecule Formation
title_fullStr Fibroblast Growth Factor 23 Predicts Left Ventricular Mass and Induces Cell Adhesion Molecule Formation
title_full_unstemmed Fibroblast Growth Factor 23 Predicts Left Ventricular Mass and Induces Cell Adhesion Molecule Formation
title_short Fibroblast Growth Factor 23 Predicts Left Ventricular Mass and Induces Cell Adhesion Molecule Formation
title_sort fibroblast growth factor 23 predicts left ventricular mass and induces cell adhesion molecule formation
url http://dx.doi.org/10.4061/2011/297070
work_keys_str_mv AT kathrynkstevens fibroblastgrowthfactor23predictsleftventricularmassandinducescelladhesionmoleculeformation
AT emilypmcquarrie fibroblastgrowthfactor23predictsleftventricularmassandinducescelladhesionmoleculeformation
AT williamsands fibroblastgrowthfactor23predictsleftventricularmassandinducescelladhesionmoleculeformation
AT diannezhillyard fibroblastgrowthfactor23predictsleftventricularmassandinducescelladhesionmoleculeformation
AT rajankpatel fibroblastgrowthfactor23predictsleftventricularmassandinducescelladhesionmoleculeformation
AT patrickbmark fibroblastgrowthfactor23predictsleftventricularmassandinducescelladhesionmoleculeformation
AT alangjardine fibroblastgrowthfactor23predictsleftventricularmassandinducescelladhesionmoleculeformation